Edgar B. Cale - 13 Jun 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Interim CEO, GC & Corp. Sec.
Signature
/s/ Edgar Cale
Issuer symbol
PASG
Transactions as of
13 Jun 2022
Net transactions value
$0
Form type
4
Filing time
15 Jun 2022, 17:22:24 UTC
Previous filing
01 Jun 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (right to buy) Award $0 +106,000 $0.000000 106,000 13 Jun 2022 Common Stock 106,000 $2.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.